Corvus Pharmaceuticals, Inc.'s (NASDAQ:CRVS) stock price dropped 12% last week; retail investors would not be happy

By Yahoo! Finance | Jun 20, 2024 at 08:18 AM EST

Retail investors hold the majority of shares in Corvus Pharmaceuticals, Inc. Institutions and hedge funds also have significant ownership. Insider ownership is positive, and the general public holds a substantial stake. Private equity firms own 16% of the company.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.